26585 Baricitinib for the treatment of pediatric patients with moderate-to-severe atopic dermatitis

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2021
This article has no abstract
Epistemonikos ID: 1febd45d93a3c91543c8d46aad683cbf64b26d5a
First added on: Feb 13, 2025